Dantrolene in the treatment of MDMA-related hyperpyrexia: a systematic review.
CJEM September 2010 Brian E Grunau, Matthew O Wiens, Jeffrey R Brubacher
The use of dantrolene in the treatment of hyperpyrexia related to MDMA (3,4-methylenedioxymethamphetamine) is controversial, with little data available to guide clinical decision-making. Although the treatment is recommended by several poison control centres, published data are primarily in the form of case reports and animal and in vitro experiments. We conducted a systematic review to...